Most cases of necrobiotic xanthogranuloma (NXG) occur in association with a monoclonal gammopathy such as MGUS. However, this study explores a much rarer possibility: that some patients may develop NXG because of an underlying genetic mutation rather than a plasma cell disorder.
Using genetic analysis, the researchers identified molecular pathways that may contribute to the development of NXG in these patients. The findings improve our understanding of the disease biology and suggest that NXG may not always arise through the same mechanism.
While genetic forms of NXG appear to be uncommon, this study expands our understanding of how NXG can develop. While most published research continues to support a strong association between NXG and monoclonal gammopathies, this paper suggests that a small number of patients may develop NXG through different biological pathways.
Understanding these differences may eventually help researchers identify distinct subtypes of NXG and develop more personalized treatment approaches.
Chen PY, Tang ZL, Hong YY, et al. Genetic Aspects of Necrobiotic Xanthogranuloma. JAMA Dermatology. 2024.
Leave a Reply